Skip to content
akaturk Academic measurement
Sign in Sign up

Academician

ÖMER DİZDAR

PROFESÖR

HACETTEPE ÜNİVERSİTESİ KANSER ENSTİTÜSÜ PREVANTİF VE ONKOLOJİ ANABİLİM DALI

Research topics OpenAlex
Academic summary YÖKSİS and OpenAlex counted separately.
Articles 146
YÖKSİS146 OpenAlex0
Projects 6
Books 10
Proceedings 40

Citation impact

OpenAlex YÖKSİS articles matched in OpenAlex: 18
h-index 9 Percentile in Türkiye: 84 #281 of 1,074 at their university by h-index
i10-index
9
Total citations
961
Top 4.9% in Türkiye
Per article
53.4
FWCI
2.84
1.00 = world average
World top 1%
2
World top 10%
6

Most cited articles

  1. Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer 2020 world top 1% 380 citations
  2. Rituximab related viral infections in lymphoma patients 2009 world top 1% 254 citations
  3. Increased cancer risk in patients with periodontitis 2017 world top 10% 119 citations

h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included.

Field ranking

YÖKSİS ?

Index quartiles

?
Scopus (SJR) 126
  • Q1 49
  • Q2 45
  • Q3 25
  • Q4 7
WoS (JCR) 124
  • Q1 38
  • Q2 25
  • Q3 36
  • Q4 25
TR Index TR Index

8 articles

OpenAlex citation percentile
  • Top 1% 2
  • Top 10% 7
  • Avg 67.8%
  • n 19
Other counts

Scopus (SJR)

  • YÖKSİS rows 130

WoS (JCR)

  • YÖKSİS rows 128

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

Journals with publications

68 journals
Scopus (SJR)
Q1 49 Q2 45 Q3 25 Q4 7
WoS (JCR)
Q1 38 Q2 25 Q3 36 Q4 25
TR Index
8 articles

Article list

  1. 2025 The association between HALP score and survival in patients treated with immune checkpoint inhibitors Expert Review of Anticancer Therapy DOI 10.1080/14737140.2025.2451079 YÖKSİS SJR Q2 JCR Q3
  2. 2025 Serum Albumin–Creatinine Ratio and Anthracycline Cardiotoxicity in Patients with Cancer Journal of Clinical Medicine DOI 10.3390/jcm14051741 YÖKSİS SJR Q2 JCR Q1
  3. 2025 Definitive radiotherapy for unresectable extrahepatic cholangiocarcinoma: is it time for an update? Radiation Oncology Journal DOI 10.3857/roj.2024.00437 YÖKSİS SJR Q2 JCR Q3
  4. 2025 Induction chemotherapy followed by definitive chemoradiation in patients with inoperable esophageal squamous cell carcinoma: a multicenter retrospective study Discover Oncology DOI 10.1007/s12672-025-03962-6 YÖKSİS SJR Q2 JCR Q3
  5. 2025 AKR1B1 Expression in the Colorectal Tumor Microenvironment Contributes Towards Its Prognostic Significance Cancer Medicine DOI 10.1002/cam4.70974 YÖKSİS SJR Q1 JCR Q2
  6. 2025 Prognostic value of serum albumin-creatinine ratio as a biomarker in patients treated with immune checkpoint inhibitors Immunotherapy DOI 10.1080/1750743X.2025.2513850 YÖKSİS SJR Q3 JCR Q3
  7. 2025 Sirolimus experience in adult patients with vascular malformations Vascular DOI 10.1177/17085381241241853 YÖKSİS SJR Q2 JCR Q4
  8. 2025 Albumin-myosteatosis gauge as a prognostic biomarker in patients treated with immune checkpoint inhibitors Immunotherapy DOI 10.1080/1750743X.2025.2525743 YÖKSİS SJR Q3 JCR Q3
  9. 2025 The association between blood sodium levels and survival in patients treated with immune checkpoint inhibitors Expert Review of Molecular Diagnostics DOI 10.1080/14737159.2025.2472946 YÖKSİS SJR Q1 JCR Q1
  10. 2025 Clinical Characteristics and Management of Patients Admitted to the Supportive Care Clinic and Predisposing Factors of Unplanned Hospital Readmission: Single-Center Experience Journal of Clinical Medicine DOI 10.3390/jcm14082679 YÖKSİS SJR Q2 JCR Q1
  11. 2025 SANO trial: innovations, risks, and unanswered questions The Lancet Oncology DOI 10.1016/S1470-2045(25)00230-X YÖKSİS SJR Q1 JCR Q1
  12. 2025 Evaluation of KRAS and NRAS mutations in metastatic colorectal cancer: an 8‐year study of 10 754 patients in Turkey Molecular Oncology DOI 10.1002/1878-0261.70042 YÖKSİS SJR Q1 JCR Q2
  13. 2025 Oxaliplatin Dosing and Toxicity: A Cautionary Perspective on Efficacy Journal of Clinical Oncology DOI 10.1200/JCO-25-01549 YÖKSİS SJR Q1 JCR Q1
  14. 2025 Addressing barriers to and strategies for herpes zoster vaccination in immunocompromised patients in Türkiye: an expert consensus Expert Review of Vaccines DOI 10.1080/14760584.2025.2550979 YÖKSİS SJR Q1 JCR Q1
  15. 2025 Medication regimen complexity in cancer patients: an overlooked issue for healthcare team Supportive Care in Cancer DOI 10.1007/s00520-025-09476-9 YÖKSİS SJR Q1 JCR Q1
  16. 2025 Assessment of the correlation between visceral adiposity and liver fat in metastatic colorectal cancer patients International Journal of Colorectal Disease DOI 10.1007/s00384-025-04967-x YÖKSİS SJR Q2 JCR Q1
  17. 2024 PD-L1 Expression for Tailoring Treatment in Advanced Melanoma—It Is Never That Easy JAMA Oncology DOI 10.1001/jamaoncol.2024.4902 YÖKSİS SJR Q1 JCR Q1
  18. 2024 Sonographic Measurements of Rectus Femoris Muscle Thickness Strongly Predict Neutropenia in Cancer Patients Receiving Chemotherapy Cancers DOI 10.3390/cancers16051061 YÖKSİS SJR Q1 JCR Q2
  19. 2024 Impact of opioid analgesics on survival in cancer patients receiving immune checkpoint inhibitors Supportive Care in Cancer DOI 10.1007/s00520-024-08681-2 YÖKSİS SJR Q1 JCR Q1
  20. 2024 Albumin-myosteatosis gauge as a prognostic factor in patients with advanced pancreatic cancer undergoing first-line chemotherapy International Journal of Clinical Oncology DOI 10.1007/s10147-024-02512-4 YÖKSİS SJR Q1 JCR Q2

Back to academicians